Submitted by Anonymous (not verified) on 1 December 2025 - 12:00
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 27, Status: Authorised
Source: